Title: Vasopressin-2 receptor antagonist attenuates the ability of the lungs to clear edema in an experimental model.
Journal: American journal of respiratory cell and molecular biology 20121101
Title: Distinct receptor subtypes mediate arginine vasopressin-dependent ACTH release and intracellular calcium mobilization in rat pituitary cells.
Journal: European journal of pharmacology 20120315
Title: Neurohypophyseal hormones manipulation modulate social and anxiety-related behavior in zebrafish.
Journal: Psychopharmacology 20120301
Title: The cardioprotective effect of different doses of vasopressin (AVP) against ischemia-reperfusion injuries in the anesthetized rat heart.
Journal: Peptides 20111201
Title: V2 receptor antagonist; tolvaptan.
Journal: Electrolyte & blood pressure : E & BP 20111201
Title: Oxytocin antagonists for the management of preterm birth: a review.
Journal: American journal of perinatology 20110601
Title: Role of vasopressin V(₁A) receptor in the urethral closure reflex in rats.
Journal: American journal of physiology. Renal physiology 20110401
Title: Arginine-vasopressin V1a receptor inhibition improves neurologic outcomes following an intracerebral hemorrhagic brain injury.
Journal: Neurochemistry international 20110301
Title: The vasopressin Avpr1b receptor: molecular and pharmacological studies.
Journal: Stress (Amsterdam, Netherlands) 20110101
Title: Oxytocin and vasopressin V(1A) receptors as new therapeutic targets in assisted reproduction.
Journal: Reproductive biomedicine online 20110101
Title: Post-treatment with SR49059 improves outcomes following an intracerebral hemorrhagic stroke in mice.
Journal: Acta neurochirurgica. Supplement 20110101
Title: The oxytocin-oxytocin receptor system and its antagonists as tocolytic agents.
Journal: International journal of endocrinology 20110101
Title: cAMP/PKA-dependent increases in Ca Sparks, oscillations and SR Ca stores in retinal arteriolar myocytes after exposure to vasopressin.
Journal: Investigative ophthalmology & visual science 20100301
Title: [Vasopressin receptor antagonists and heart failure].
Journal: Therapeutische Umschau. Revue therapeutique 20091101
Title: Effects of novel vasopressin receptor antagonists on renal function and cardiac hypertrophy in rats with experimental congestive heart failure.
Journal: The Journal of pharmacology and experimental therapeutics 20080801
Title: Non-peptide arginine-vasopressin antagonists: the vaptans.
Journal: Lancet (London, England) 20080510
Title: Modulation of AQP4 expression by the selective V1a receptor antagonist, SR49059, decreases trauma-induced brain edema.
Journal: Acta neurochirurgica. Supplement 20080101
Title: The modulation of aquaporin-4 by using PKC-activator (phorbol myristate acetate) and V1a receptor antagonist (SR49059) following middle cerebral artery occlusion/reperfusion in the rat.
Journal: Acta neurochirurgica. Supplement 20080101
Title: Toward efficient drug screening by homogeneous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands.
Journal: Journal of medicinal chemistry 20071004
Title: Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones: relevance to therapy of nephrogenic diabetes insipidus.
Journal: American journal of physiology. Renal physiology 20070101
Title: Vasopressin antagonists.
Journal: Cellular and molecular life sciences : CMLS 20060801
Title: Pharmacological chaperone activity of SR49059 to functionally recover misfolded mutations of the vasopressin V1a receptor.
Journal: The Journal of biological chemistry 20060526
Title: Effects of YM218, a nonpeptide vasopressin V(1A) receptor-selective antagonist, on vasopressin-induced growth responses in human mesangial cells.
Journal: European journal of pharmacology 20060524
Title: Evidence for a role of vasopressin in the control of aldosterone secretion in primary aldosteronism: in vitro and in vivo studies.
Journal: The Journal of clinical endocrinology and metabolism 20060401
Title: Vasopressin receptor antagonists: pharmacological tools and potential therapeutic agents.
Journal: Autonomic & autacoid pharmacology 20060401
Title: Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus.
Journal: Journal of the American Society of Nephrology : JASN 20060101
Title: Protective effect of the V1a receptor antagonist SR49059 on brain edema formation following middle cerebral artery occlusion in the rat.
Journal: Acta neurochirurgica. Supplement 20060101
Title: Selectivity of d[Cha4]AVP and SSR149415 at human vasopressin and oxytocin receptors: evidence that SSR149415 is a mixed vasopressin V1b/oxytocin receptor antagonist.
Journal: British journal of pharmacology 20051101
Title: Vasotocin and vasopressin stimulation of the chloride secretion in the human bronchial epithelial cell line, 16HBE14o-.
Journal: British journal of pharmacology 20050401
Title: The effect of relcovaptan (SR 49059), an orally active vasopressin V1a receptor antagonist, on uterine contractions in preterm labor.
Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20050201
Title: Pharmacologic properties of YM218, a novel, potent, nonpeptide vasopressin V1A receptor-selective antagonist.
Journal: Vascular pharmacology 20050101
Title: Functional rescue of the constitutively internalized V2 vasopressin receptor mutant R137H by the pharmacological chaperone action of SR49059.
Journal: Molecular endocrinology (Baltimore, Md.) 20040801
Title: Participation of vasopressin in the development of cerebral vasospasm in a rat model of subarachnoid haemorrhage.
Journal: Clinical and experimental pharmacology & physiology 20040401
Title: Inhibitory effects of SR 49059 on oxytocin-and vasopressin-induced uterine contractions in non-pregnant women.
Journal: Acta obstetricia et gynecologica Scandinavica 20040101
Title: Identification of the binding sites of the SR49059 nonpeptide antagonist into the V1a vasopressin receptor using sulfydryl-reactive ligands and cysteine mutants as chemical sensors.
Journal: The Journal of biological chemistry 20031010
Title: Pancreatic vasopressin V1b receptors: characterization in In-R1-G9 cells and localization in human pancreas.
Journal: American journal of physiology. Endocrinology and metabolism 20030901
Title: Oxytocin and fetal membranes in preterm labor: current concepts and clinical implication.
Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20030601
Title: Vasopressin-induced facilitation of adrenergic responses in the rat mesenteric artery is V1-receptor dependent.
Journal: Autonomic & autacoid pharmacology 20030201
Title: Effects of nonpeptide V(1) vasopressin receptor antagonist SR-49059 on infarction volume and recovery of function in a focal embolic stroke model.
Journal: Stroke 20021201
Title: Synthesis and pharmacological evaluation of 5-(4-biphenyl)-3-methyl-4-phenyl-1,2,4-triazole derivatives as a novel class of selective antagonists for the human vasopressin V(1A) receptor.
Journal: Journal of medicinal chemistry 20020606
Title: Interplay between presynaptic and postsynaptic activities is required for dendritic plasticity and synaptogenesis in the supraoptic nucleus.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20020101
Title: Placental transfer of SR49059 in the human dually perfused cotyledon in vitro.
Journal: Placenta 20011101
Title: Vascular and renal effects of vasopressin and its antagonists in conscious rats with chronic myocardial infarction; evidence for receptor shift.
Journal: European journal of pharmacology 20010706
Title: Effects of YM471, a nonpeptide AVP V(1A) and V(2) receptor antagonist, on human AVP receptor subtypes expressed in CHO cells and oxytocin receptors in human uterine smooth muscle cells.
Journal: British journal of pharmacology 20010701
Title: A nonpeptide vasopressin V(1a) receptor antagonist, SR 49059, does not prevent cisplatin-induced emesis in piglets.
Journal: Fundamental & clinical pharmacology 20010601
Title: High concentrations of oxytocin cause vasoconstriction by activating vasopressin V1A receptors in the isolated perfused rat kidney.
Journal: Naunyn-Schmiedeberg's archives of pharmacology 20010401
Title: Nitric oxide, but not vasopressin V2 receptor-mediated vasodilation, modulates vasopressin-induced renal vasoconstriction in rats.
Journal: Naunyn-Schmiedeberg's archives of pharmacology 20000301
Title: Vasopressin does not effect hypertension caused by long-term nitric oxide inhibition.
Journal: Hypertension (Dallas, Tex. : 1979) 20000201
Title: Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women.
Journal: British journal of obstetrics and gynaecology 19991001
Title: Oxytocin and vasopressin constrict rat isolated uterine resistance arteries by activating vasopressin V1A receptors.
Journal: European journal of pharmacology 19990702
Title: Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells.
Journal: British journal of pharmacology 19981201
Title: Mapping peptide-binding domains of the human V1a vasopressin receptor with a photoactivatable linear peptide antagonist.
Journal: The Journal of biological chemistry 19971017
Title: The human V3 pituitary vasopressin receptor: ligand binding profile and density-dependent signaling pathways.
Journal: Endocrinology 19971001
Title: Binding of [3H] SR 49059, a potent nonpeptide vasopressin V1a antagonist, to rat and human liver membranes.
Journal: Biochemical and biophysical research communications 19940227
Title: Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor.
Journal: The Journal of biological chemistry 19940204
